Genertec Universal Medical Group Company Limited (Genertec Universal Medical) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd., will launch the first tranche of domestic medium-term notes (T1 Notes) for 2026 in the PRC inter-bank bond market.
Key terms • Registered programme: up to RMB3.00 billion; outstanding quota before this tranche stood at RMB2.50 billion. • Tranche size: RMB0.50 billion. • Tenor: two years. • Coupon: fixed rate to be determined through book-building. • Par value / Issue price: RMB100.00 per note. • Credit rating: AAA for the Issuer. • Expected trading commencement: 27 April 2026 on the PRC inter-bank bond market.
Use of proceeds Net proceeds will be applied to repay maturing debts of China Universal Leasing.
Underwriting syndicate China CITIC Bank Corporation Limited and Postal Savings Bank of China Co., Ltd. serve as joint lead underwriters.
Genertec Universal Medical will release further updates on the issuance in line with regulatory requirements.
Comments